TURKISH JOURNAL OF GASTROENTEROLOGY, vol.30, no.9, pp.801-806, 2019 (SCI-Expanded)
Background/Aims: Hepatitis C virus (HCV) infection is known to impair the quality of life (QoL). Increased levels of anxiety and depression have been found in HCV infection with a prevalence of 28% and 33%, respectively. Our aim was to investigate depression, anxiety, and QoL of chronic hepatitis C (CHC) patients before and after treatment with a direct-acting antiviral agent (DAAA).